Vivani Medical VANI
NASDAQ VANI
$1.22 -0.02 (-1.61%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vivani Medical (VANI) Liabilities and Shareholders Equity (2014 - 2026)

Updated

Vivani Medical (VANI) reported Liabilities and Shareholders Equity of $41.64 million for Q2 2026, up 44.1% from $28.91 million a year earlier but down 1.7% from the prior quarter.

Analysis

Vivani Medical (VANI) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

At the end of FY2025, Vivani Medical posted Liabilities and Shareholders Equity of $39.39 million, down 5.2% from FY2024.

  • Liabilities and Shareholders Equity has declined for three consecutive years, though with a five-year compound annual growth rate of 54.6% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $41.56 million in FY2024 (-9.2%), $45.8 million in FY2023 (-10.4%), $51.13 million in FY2022 (+837.6%) and $5.45 million in FY2021 (+22.3%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $5.45 million in Q4 2021 and a high of $73.63 million in Q3 2021.
  • Year over year, Liabilities and Shareholders Equity gained in two of the last eight quarters, with an average decline of 10.8%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2022 (growth of 837.6%); the low point was Q3 2025 (a decline of 41.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $42.35 million (Q1 2026), $39.39 million (Q4 2025) and $25.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Vivani Medical 110.87 Mn 52.37 Mn - 41.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.64 Mn
Mar 31, 2026 42.35 Mn
Dec 31, 2025 39.39 Mn
Sep 30, 2025 25.05 Mn
Jun 30, 2025 28.91 Mn
Mar 31, 2025 35.45 Mn
Dec 31, 2024 41.56 Mn
Sep 30, 2024 42.90 Mn
Jun 30, 2024 48.22 Mn
Mar 31, 2024 53.79 Mn
Dec 31, 2023 45.80 Mn
Sep 30, 2023 53.32 Mn
Jun 30, 2023 59.61 Mn
Mar 31, 2023 44.58 Mn
Dec 31, 2022 51.13 Mn
Sep 30, 2022 57.02 Mn
Jun 30, 2022 65.65 Mn
Mar 31, 2022 68.54 Mn
Dec 31, 2021 5.45 Mn
Sep 30, 2021 73.63 Mn
API Access

Vivani Medical Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VANI&period=max&api_key=YOUR_API_KEY